http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-34909-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2013-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c273812c9d35781491489a2def22b974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb6c2b48d9ce176a36ba3a7bbf90b60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad94e289119a3199f8a7458982ba9ded
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5fe2a28b1830d58b6bdc741fbac6c3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3ea8326276175f2ce2e6c36eebdf5db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99e435c76dbfc9b225c92b8f62995eb0
publicationDate 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-34909-A
titleOfInvention ANTI-TUMORAL COMPOSITION INCLUDING COMPOUND 1- (6 - {[6- (4-FLUOROPHENIL) [1,2,4] TRIAZOLO [4,3-B] PIRIDAZIN-3-IL] SULFANIL} -1,3- BENZOTIAZOL-2-IL) -3- (2-MORFOLIN-4-ILETIL) UREA.
abstract The present invention relates to an anti-tumor composition comprising the compound 1- (6 - {[6- (4-fluorophenyl) [1,2,4] triazolo [4,3-b] pyridazin-3-yl] sulfanil} -1,3-benzothiazol-2-yl) -3- (2-morpholin-4-ylethyl) urea and its use in the treatment of cancer.
priorityDate 2012-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5333

Total number of triples: 32.